takeda in talks to buy nycomed for as much as $14 billion
takeda pharmaceutical is in talks to buy its swiss rival nycomed for up to $14 billion, a person with direct knowledge of the matter said thursday.
http://feeds.nytimes.com/click.phdo?i=5c3ba355c128ef077a6a756ee1ff22b7
12280
13 May 2011 00:09:45
nyt
business